Nasdaq
RARE
Ultragenyx Pharmaceutical Inc.
- Health Care
- Listed 2014
- 1 day
- +3.6%
- 1 month
- −28.0%
- 1 year
- −8.0%
$25.82 · Mkt cap $2.54B
At the 6 Aug 2026 close
Nasdaq
Ultragenyx Pharmaceutical Inc.
$25.82 · Mkt cap $2.54B
At the 6 Aug 2026 close
Ultragenyx Pharmaceutical Inc. trades under the ticker RARE on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2014. Its market capitalisation is $2.54B. The last closing price was $25.82, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −8.0%, and −28.0% over the past month. Returns are price returns and exclude dividends.
This page exists because RARE is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.